GNPX Genprex, Inc.: institutional ownership and insider trading
25 funds reported holding $154K of Genprex, Inc. in their latest 13F filings; in Q2 2026 funds net bought $106K, with 5 new positions and 8 funds selling out; over the last 12 months insiders bought $0 and sold $22 on the open market.
GNPX revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$4.45M
- Quarter ended Mar 31, 2026: revenue n/a, net income −$4.46M
- Quarter ended Dec 31, 2025: revenue n/a, net income −$3.79M
- Quarter ended Sep 30, 2025: revenue n/a, net income −$3.80M
Largest institutional holders of GNPX
- VANGUARD FIDUCIARY TRUST CO — $40.5K
- HRT FINANCIAL LP — $37.0K
- GEODE CAPITAL MANAGEMENT, LLC — $31.3K
- VANGUARD CAPITAL MANAGEMENT LLC — $18.9K
- Engineers Gate Manager LP — $10.8K
- Mayflower Financial Advisors, LLC — $10.4K
- UBS Group AG (UBS) — $2.33K
- Tower Research Capital LLC (TRC) — $1.48K
- BARCLAYS PLC (BCS, BCLYF) — $819
- JONES FINANCIAL COMPANIES LLLP — $597
Recent GNPX insider trades
- Apr 14, 2026: Longnecker Brent M sold 18 shares ($22)
Members of Congress trading GNPX
- Feb 5, 2026: Tim Moore bought $1.00K–$15.0K
- Dec 18, 2025: Tim Moore bought $1.00K–$15.0K
- Nov 7, 2025: Tim Moore bought $1.00K–$15.0K
- Oct 29, 2025: Tim Moore bought $15.0K–$50.0K
Who owns the most GNPX stock?
The largest institutional holders of Genprex, Inc. in the latest 13F filings are VANGUARD FIDUCIARY TRUST CO ($40.5K), HRT FINANCIAL LP ($37.0K), GEODE CAPITAL MANAGEMENT, LLC ($31.3K).
Are insiders buying or selling GNPX?
Over the last 12 months insiders bought $0 and sold $22 of Genprex, Inc. stock on the open market (SEC Form 4).